My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 715 / DOI: 10.3332/ecancer.2017.715

Review

Bone metastasis risk factors in breast cancer

Bone is the single most frequent site for bone metastasis in breast cancer patients. Patients with bone-only metastasis have a fairly good prognosis when compared with patients with visceral disease. Nevertheless, cancer-induced bone disease carries an important risk of developing skeletal related events that impact quality of life (QoL). It is therefore particularly important to stratify patients according to their risk of developing bone metastasis. In this context, several risk factors have been studied, including demographic, clinicopathological, genetic, and metabolic factors. Most of them show conflicting or non-definitive associations and are not validated for clinical use. Nonetheless, tumour intrinsic subtype is widely accepted as a major risk factor for bone metastasis development and luminal breast cancer carries an increased risk for bone disease. Other factors such as gene signatures, expression of specific cytokines (such as bone sialoprotein and bone morphogenetic protein 7) or components of the extracellular matrix (like bone crosslinked C-telopeptide) might also influence the development of bone metastasis. Knowledge of risk factors related with bone disease is of paramount importance as it might be a prediction tool for triggering the use of targeted agents and allow for better patient selection for future clinical trials.

Keywords: bone metastases, breast cancer, risk factor

Categories:

Breast Bone

Loading Article Metrics ... Please wait

Related articles

Clinical Study: Pre-operative axillary staging: should core biopsy be preferred to fine needle aspiration cytology?

Abstract | Full Article | PDF Published: 07 Mar 2017 / DOI: 10.3332/ecancer.2017.724

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Abstract | Full Article | PDF Published: 16 Dec 2016 / DOI: 10.3332/ecancer.2016.703

Review: The neutrophil-to-lymphocyte ratio: a narrative review

Abstract | Full Article | PDF Published: 12 Dec 2016 / DOI: 10.3332/ecancer.2016.702

Review: The current status of prophylactic femoral intramedullary nailing for metastatic cancer

Abstract | Full Article | PDF Published: 01 Dec 2016 / DOI: 10.3332/ecancer.2016.698

Case Report: Radiation-induced breast angiosarcoma: a case report

Abstract | Full Article | PDF | Spanish Published: 29 Nov 2016 / DOI: 10.3332/ecancer.2016.697



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence